Xultophy®

DRUG2 trials

Sponsors

Tonghua Dongbao Pharmaceutical Co.,Ltd

Conditions

HealthyType 2 Diabetes

Phase 1

A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects

RecruitingNCT06449703

Tonghua Dongbao Pharmaceutical Co.,LtdHealthy

Start: 2024-05-06End: 2024-06-16Target: 44Updated: 2024-06-10

Phase 3

A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes

Not yet recruitingNCT06559722

Tonghua Dongbao Pharmaceutical Co.,LtdType 2 Diabetes

Start: 2024-08-31End: 2026-02-28Target: 510Updated: 2024-08-19